ES2133412T3 - 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma. - Google Patents
2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma.Info
- Publication number
- ES2133412T3 ES2133412T3 ES93920816T ES93920816T ES2133412T3 ES 2133412 T3 ES2133412 T3 ES 2133412T3 ES 93920816 T ES93920816 T ES 93920816T ES 93920816 T ES93920816 T ES 93920816T ES 2133412 T3 ES2133412 T3 ES 2133412T3
- Authority
- ES
- Spain
- Prior art keywords
- cyclophosphates
- oligoadenylates
- oligoadenylate
- activity
- papiloma virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
EL OBJETO DE LA INVENCION SON NUEVOS 2 '' ,5 '' OLIGOADENILATOS-2{SUP,''},3{SUP,''}-CICLOFOSFATOS DE FORMULA (I), DONDE 0 <= N <= 10, ESPECIALMENTE 1 O 2, PARA MEDICAMENTOS QUE LLEVAN ESTOS PRINCIPIOS ACTIVOS Y SU UTILIZACION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1993/002596 WO1995008555A1 (de) | 1993-09-24 | 1993-09-24 | 2',5'-oligoadenylat-2',3'-cyclophosphate |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2133412T3 true ES2133412T3 (es) | 1999-09-16 |
Family
ID=8165765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93920816T Expired - Lifetime ES2133412T3 (es) | 1993-09-24 | 1993-09-24 | 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma. |
Country Status (9)
Country | Link |
---|---|
US (2) | US5739013A (es) |
EP (1) | EP0721457B1 (es) |
JP (1) | JPH09509647A (es) |
KR (1) | KR100332250B1 (es) |
DE (1) | DE69324826D1 (es) |
DK (1) | DK0721457T3 (es) |
ES (1) | ES2133412T3 (es) |
GR (1) | GR3030863T3 (es) |
WO (1) | WO1995008555A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040127446A1 (en) * | 1992-05-14 | 2004-07-01 | Lawrence Blatt | Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication |
DK0721457T3 (da) * | 1993-09-24 | 1999-11-08 | Edward I Budowsky | 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet |
US5955446A (en) * | 1997-01-16 | 1999-09-21 | Pentose Pharmaceuticals, Inc. | Method of treating herpes infections with 2',5'-oligoadenylate-2',3'-cyclophosphate compounds |
US20070099170A1 (en) * | 1998-07-21 | 2007-05-03 | Navigant Biotechnologies, Inc. | Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate |
US7498156B2 (en) * | 1998-07-21 | 2009-03-03 | Caridianbct Biotechnologies, Llc | Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components |
US6258577B1 (en) | 1998-07-21 | 2001-07-10 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers |
US7049110B2 (en) * | 1998-07-21 | 2006-05-23 | Gambro, Inc. | Inactivation of West Nile virus and malaria using photosensitizers |
JP2002541822A (ja) * | 1999-04-14 | 2002-12-10 | エム ユー エス シー ファンデーション フォー リサーチ ディベロップメント | 組織特異的および病原体特異的毒性物質ならびにリボザイム |
JP2003510281A (ja) * | 1999-09-29 | 2003-03-18 | ザ クリーブランド クリニック ファウンデーション | 2−5aおよびインターフェロンを用いる治療 |
US6268120B1 (en) | 1999-10-19 | 2001-07-31 | Gambro, Inc. | Isoalloxazine derivatives to neutralize biological contaminants |
US7648699B2 (en) * | 2000-06-02 | 2010-01-19 | Caridianbct Biotechnologies, Llc | Preventing transfusion related complications in a recipient of a blood transfusion |
TW590780B (en) * | 2000-06-02 | 2004-06-11 | Gambro Inc | Additive solutions containing riboflavin |
US7985588B2 (en) * | 2000-06-02 | 2011-07-26 | Caridianbct Biotechnologies, Llc | Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light |
US6843961B2 (en) * | 2000-06-15 | 2005-01-18 | Gambro, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
US20020123480A1 (en) * | 2000-10-24 | 2002-09-05 | Edson Clark M. | Methods and compositions utilizing 2'-5' oligoadenylates in the treatment of disorders of cell proliferation |
JP2005537028A (ja) * | 2002-06-26 | 2005-12-08 | ザ ペン ステート リサーチ ファウンデーション | ヒト乳頭腫ウイルス感染症を治療する方法及び材料 |
US7134395B2 (en) * | 2004-01-20 | 2006-11-14 | Southern Lithoplate, Inc. | Acid inkjet imaging of lithographic printing plates |
KR20210062430A (ko) | 2019-11-21 | 2021-05-31 | 대한민국(전북기계공업고등학교장) | 동력 전달 장치를 활용한 교육 시스템 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5312891A (en) * | 1976-07-23 | 1978-02-04 | Kikkoman Corp | Novel 1,n6-etheno-2-substituted-adenosine-3,5-cyclic phosphoric acid |
IL58421A (en) * | 1979-10-09 | 1984-01-31 | Yeda Res & Dev | Production of(2'-5')oligoisoadenylate and pharmaceutical compositions containing it |
US4859768A (en) * | 1984-07-11 | 1989-08-22 | Temple University Of The Commonwealth System Of Higher Education | Derivatives of 2', 5'-oligoadenylate and antiviral uses thereof |
US5550111A (en) * | 1984-07-11 | 1996-08-27 | Temple University-Of The Commonwealth System Of Higher Education | Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
DE4211238C2 (de) * | 1992-04-03 | 1994-10-27 | Edward I Budowskij | Verwendung von 2',5'-Oligoadenylaten zur Behandlung von Papillomatosen |
DK0721457T3 (da) * | 1993-09-24 | 1999-11-08 | Edward I Budowsky | 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet |
-
1993
- 1993-09-24 DK DK93920816T patent/DK0721457T3/da active
- 1993-09-24 EP EP93920816A patent/EP0721457B1/de not_active Expired - Lifetime
- 1993-09-24 US US08/615,246 patent/US5739013A/en not_active Expired - Lifetime
- 1993-09-24 WO PCT/EP1993/002596 patent/WO1995008555A1/de active IP Right Grant
- 1993-09-24 JP JP7509512A patent/JPH09509647A/ja not_active Ceased
- 1993-09-24 ES ES93920816T patent/ES2133412T3/es not_active Expired - Lifetime
- 1993-09-24 KR KR1019960701492A patent/KR100332250B1/ko not_active IP Right Cessation
- 1993-09-24 DE DE69324826T patent/DE69324826D1/de not_active Expired - Fee Related
-
1997
- 1997-11-26 US US08/979,926 patent/US5962431A/en not_active Expired - Fee Related
-
1999
- 1999-07-27 GR GR990401949T patent/GR3030863T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH09509647A (ja) | 1997-09-30 |
WO1995008555A1 (de) | 1995-03-30 |
EP0721457A1 (de) | 1996-07-17 |
US5962431A (en) | 1999-10-05 |
DK0721457T3 (da) | 1999-11-08 |
GR3030863T3 (en) | 1999-11-30 |
EP0721457B1 (de) | 1999-05-06 |
DE69324826D1 (de) | 1999-06-10 |
KR960704911A (ko) | 1996-10-09 |
KR100332250B1 (ko) | 2002-12-05 |
US5739013A (en) | 1998-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2133412T3 (es) | 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma. | |
ES2164182T3 (es) | Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana. | |
ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
DE69334186D1 (de) | Vom MAGE-3-Gen en abgeleitetes und von HLA-A1 präsentiertes, isoliertes Nonapeptid und dessen Anwendungen | |
ES2080739T3 (es) | Nitro-compuestos insecticidamente activos. | |
NO307336B1 (no) | 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
SV1995000042A (es) | Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv | |
ES2093979T3 (es) | Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino)fenilacetico y su procedimiento de preparacion. | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
DE69432984D1 (de) | Therapeutische substituierte guanidine | |
IT1285770B1 (it) | Composti corticoidei | |
ES2056180T3 (es) | Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina. | |
ES2170822T3 (es) | Formulacion liquida de 1,2-bencisotiazolin-3-ona. | |
ES2136725T3 (es) | Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo. | |
ES2032955T3 (es) | Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida. | |
BR0007514A (pt) | Macrolìdeos com atividade anti-inflamatória | |
IT9019754A0 (it) | Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica | |
ITMI921551A1 (it) | Glutatione come agente chemioprotettivo | |
AR009809A1 (es) | Derivados de 10,13,15-trioxatriciclo[9.2.1(9.6)]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos | |
TR199901209T2 (xx) | B�cek �ld�r�c� ve mitisidal kompozisyonlar | |
PA7801701A1 (es) | Compuestos ariltios | |
ATE28188T1 (de) | Antikonvulsive mittel. | |
ES2118248T3 (es) | Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos. | |
ES2152315T3 (es) | Xamoneline tartrato. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 721457 Country of ref document: ES |